Eumetazoa Details: NCBI 6072, gram-negative or unknown [clade]
| Eumetazoa
Diversity of Organisms:
- Eumetazoa includes organisms ranging from simple multicellular animals to highly complex and specialized forms. This diversity encompasses invertebrates like insects, mollusks, and crustaceans, as well as vertebrates like fish, amphibians, reptiles, birds, and mammals.
Ecological Roles:
- Eumetazoans play crucial roles in ecosystems as consumers, decomposers, and contributors to nutrient cycling. Many are integral parts of food webs, serving as prey and predators.
Economic Importance:
- Several Eumetazoan species have significant economic importance. For example, certain fish and shellfish species are important for human consumption, and others are economically valuable in agriculture (e.g., pollinators like bees) or as pets.
Model Organisms:
- Some Eumetazoans, particularly certain species of insects, fish, and mammals, serve as model organisms in scientific research. Studies on these organisms contribute to our understanding of genetics, development, physiology, and diseases, benefiting both human and animal health.
Zoonotic Diseases:
- Certain Eumetazoans can act as hosts for zoonotic diseases—diseases that can be transmitted between animals and humans. Examples include diseases transmitted by insects (vectors) such as mosquitoes or ticks.
Conservation and Biodiversity:
- Many Eumetazoans face threats due to habitat loss, pollution, climate change, and other factors. Conservation efforts are crucial to preserving biodiversity and the ecological balance of ecosystems.
Human Health and Medicine:
- Some Eumetazoans are directly relevant to human health. For example, certain species are involved in the transmission of diseases, while others may be sources of medical compounds or models for biomedical research.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
- Immune Epitope Database
- The NCBI taxonomy database
- UniProt
- Immune Epitope Taxonomy Database (IEDB)
- AI Engines For more Details: Perplexity Kagi Labs You
 Statistics
|
NCBI | Data Punk | End Products Produced |
Lab Reporting
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Desired Levels Suggestions for Eumetazoa
- Frequency - how often do samples show this bacteria
- UD - An alternative statistical algorithm (which factors in the frequency)
- Kaltoft-Moldrup Heuristic Using uploaded data
- Lab Low and High are calculated using the formula that most labs use: Mean - 2 Standard Deviation to Mean + 2 Standard Deviation
| Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Labs | 0.93 | 10 | 1000000 | 0 | 482421 | 57172.3 | 1110 | 216963.8 | 0 | 17190 | 0 %ile | 100 %ile | ||
| biomesight | 27.75 | 0 | 10 | 10 | 50 | 0 | 271 | 42.5 | 20 | 116.8 | 20 | 60 | 0 %ile | 90 %ile |
| thorne | 24.14 | 2 | 11 | 0 | 11 | 4.6 | 3 | 3.1 | 2 | 11 | 11.1 %ile | 77.8 %ile | ||
| thryve | 0.63 | 13 | 152436 | 0 | 134708 | 21817.6 | 37 | 57597.3 | 13 | 152436 | 11.1 %ile | 77.8 %ile | ||
| ubiome | 1.39 | 21 | 1593 | 0 | 1131 | 236.2 | 66 | 456.7 | 21 | 1593 | 7.7 %ile | 84.6 %ile |
External Reference Ranges for Eumetazoa
| Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
|---|
Statistic by Lab Source for Eumetazoa
| Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
|---|---|---|---|---|---|
| BiomeSight | 28.181 % | 0.004 % | 0.011 % | 835.0 | 2963 |
| BiomeSightRdp | 70.968 % | 1.291 % | 2.371 % | 22.0 | 31 |
| custom | 1.639 % | 0.076 % | % | 1.0 | 61 |
| es-xenogene | 17.241 % | 20.02 % | 44.71 % | 5.0 | 29 |
| Medivere | 14.286 % | 0.017 % | % | 1.0 | 7 |
| SequentiaBiotech | 2.778 % | 0.069 % | % | 1.0 | 36 |
| Thorne | 28.846 % | 0.013 % | 0.03 % | 30.0 | 104 |
| Thryve | 0.576 % | 1.909 % | 5.388 % | 8.0 | 1390 |
| uBiome | 1.389 % | 0.024 % | 0.046 % | 11.0 | 792 |
|
|
To see medical conditions associated you may be logged in
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.